http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107021937-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D277-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 |
| filingDate | 2017-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107021937-B |
| titleOfInvention | Benzothiazole Carbox amide and its application |
| abstract | The invention belongs to pharmaceutical technology fields, are related to benzothiazole Carbox amide and its application.Benzothiazole Carbox amide include benzothiazole Carbox amide derivative and pharmaceutically useful salt, general structure it is as follows: wherein R 1 、R 2 , Ar is as described in claims and specification.Benzothiazole Carbox amide and the salt of the pharmaceutically useful sour addition of such compound can merge with existing drug or alone as growth factor tyrosine kinase inhibitor on epidermis, the related disease such as Small Cell Lung Cancer of imbalance is gone to for treating EGF-R ELISA signal, squamous carcinoma, gland cancer, large cell carcinoma, colorectal cancer, breast cancer, oophoroma, clear-cell carcinoma. |
| priorityDate | 2017-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 120.